1. Xinxiang Ruicheng Technology Co., Ltd.
    Sales Dept.: +86-373-7095381
    Manager Yang +86-19839906661

    About Us

    Located in the eastern section of Qinglong Road of Xinxiang Economic Development Zone, Xinxiang Ruicheng Technology Co., Ltd. is a joint-stock enterprise and a new-type technology enterprise integrating development, research, production and sales. Our company got the high-tech enterprise certification in 2015 and obtained the certification of province-level R&D center in the same year; our company successfully listed on the New Third Board (NEEQ) and officially entered the capital market in 2016. In May 2018, our company entered the innovation layer; established a subsidiary (Xinxiang Ruinuo Pharmaceutical Co., Ltd) in 2017. 

    Our products are mainly used in the production of nucleoside APIs, antiviral APIs, perindopril APIs and vitamins, etc. Our company adopts advanced production technology and leading equipment in the same industry in China, and hires high-quality technology and management talents; our company also cooperates closely with state-level research units and universities. Relying on advanced testing equipment for the quality testing and control of products, we have laid a solid foundation to ensure the good quality of products. Now, our products are commonly used in large and medium-sized APIs and vitamin production enterprises in the world, and are highly appraised by users. 

    In 2014, our company was successfully certificated to ISO9001:2008 quality system and ISO14001:2014 environmental management system. Adhering to the spirit of "advancing with the times, advocating innovation and pursuing excellence", and upholding such business philosophy of "taking market demands as orientation, talent as base, product as support, management as the link, development as goal", our company constantly improves our scientific management system of production and operation, sales and service, and strengthens the knowledgeable, professional and young enterprise team of our company; we are going to make innovation on the course of pharmaceutical intermediates constantly and working hard to provide customers with quality and efficient services.